CKChinyere Kemet

Chinyere Kemet

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chinyere Kemet has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Janitors at Work: The Multifaceted Role of the P97-UFD1-NPL4 Complex

    by Chinyere Kemet, Mackenzie Urbano, Sara Mei, Xiaodan Qin, Hui Feng

    The regulatory pathways governing protein homeostasis are a delicate balance of protein synthesis and degradation. At the core of proteolysis is a molecular “cleaning crew” composed of the P97 ATPase, ubiquitin fusion degradation 1 (UFD1), and nuclear protein localization 4 (NPL4). The ATPase activity of P97 drives the formation and activity of this complex, which is also regulated by post-translational modifications and ubiquitin regulatory X-domain proteins. Notably, the P97-UFD1-NPL4 complex plays a critical role in endoplasmic reticulum-associated degradation (ERAD), by retrotranslocating misfolded proteins from the endoplasmic reticulum (ER) to the cytosol. Beyond ERAD, this complex also targets proteins from mitochondria, ribosomes, and chromatin to regulate cellular processes such as organelle homeostasis, cell cycle progression, DNA replication, and DNA repair. The aberrant activity of the P97-UFD1-NPL4 complex can either accelerate or impair the removal of misfolded, unfolded, and regulatory proteins, disrupting cellular homeostasis and inducing various disorders. Significant efforts have been made to develop therapeutics that inhibit complex functions. However, to identify a suitable strategy, it is crucial to understand the molecular mechanisms linking the function of the complex to disease progression. In this review, we summarize the multifaceted roles of the P97-UFD1-NPL4 complex in protein quality control, discuss how its dysfunction leads to disease, and explore ongoing strategies to target the complex.

  • Open Access

    CKLF instigates a “cold” microenvironment to promote MYCN-mediated tumor aggressiveness

    by Xiaodan Qin, Andrew Lam, Xu Zhang, Satyaki Sengupta, J. Bryan Iorgulescu, Hongru Ni, Sanjukta Das, Madison Rager, Zhenwei Zhou, Tao Zuo, et al.

    Solid tumors, especially those with aberrant MYCN activation, often harbor an immunosuppressive microenvironment to fuel malignant growth and trigger treatment resistance. Despite this knowledge, there are no effective strategies to tackle this problem. We found that chemokine-like factor ( CKLF ) is highly expressed by various solid tumor cells and transcriptionally up-regulated by MYCN. Using the MYCN-driven high-risk neuroblastoma as a model system, we demonstrated that as early as the premalignant stage, tumor cells secrete CKLF to attract CCR4-expressing CD4 + cells, inducing immunosuppression and tumor aggression. Genetic depletion of CD4 + T regulatory cells abolishes the immunorestrictive and protumorigenic effects of CKLF. Our work supports that disrupting CKLF-mediated cross-talk between tumor and CD4 + suppressor cells represents a promising immunotherapeutic approach to battling MYCN-driven tumors.


  • Open Access

    Fishing for drugs

    by Chinyere Kemet, Emily Hill, Hui Feng

    Screening for drugs that disrupt embryonic development in zebrafish can help identify treatments that suppress metastasis.